Transforming therapeutics to make a difference in patient health

Our unique, injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes across multiple therapeutic areas.

AmacaThera’s Sci­ence

Grounded in the research of world-renowned biomaterials scientist, Dr. Molly Shoichet, we’re developing products at the intersection of biomaterials and pharmaceuticals.

Yellow Needles

Our Team

We’ve brought together commercial leaders, researchers and biotechnology experts that will transform therapeutics development while making a difference in patient outcomes.

Team

Recent News

How AMT-143 could reduce the post-surgical need for opioids

   Press Release

In June 2022, we created and published “Meet AmacaThera and learn about our novel hydrogel platform,” a 35-second animation. Watch the animated explainer inside this article.Read more

AmacaThera featured in Innovate Toronto

   Media Coverage

AmacaThera’s drug development platform is featured in Innovate Toronto, an in-depth look at Toronto’s innovation ecosystem. The online compendium and coffee table book features over 300 start-up success stories, including Kepler, which aims to take the Internet into space, and Altus Assessments, which is using data and tech to bring the human side of healthcare education back into focus.
Read more

AmacaThera animation showcases company’s unique biotechnology

   Press Release

In June 2022, we created and published “Meet AmacaThera and learn about our novel hydrogel platform,” a one-minute animation that outlines its approach to drug development.Read more